You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Argentina Patent: 090253


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 090253

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,730,879 Mar 5, 2033 Gilead Sciences Inc ZYDELIG idelalisib
8,865,730 Mar 5, 2033 Gilead Sciences Inc ZYDELIG idelalisib
9,469,643 Sep 2, 2033 Gilead Sciences Inc ZYDELIG idelalisib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of AR090253: Scope, Claims, and Patent Landscape in Argentina

Last updated: July 29, 2025

Introduction

Patent AR090253, granted in Argentina, pertains to a pharmaceutical invention with specific claims aimed at protecting a unique formulation or therapeutic method. Examining its scope and claims provides crucial insights into its legal strength, commercial potential, and the landscape of related patents. This analysis delineates the patent’s coverage, its strategic position within the Argentine patent environment, and implications for stakeholders.

Patent Overview

AR090253 was granted by the National Institute of Industrial Property (INPI) in Argentina. While specific details such as filing date, publication number, or applicant are not provided here, the patent’s textual scope typically encompasses claims that define the invention’s bounds.

Timeline & Context:
Argentine patent law aligns closely with TRIPS (Trade-Related Aspects of Intellectual Property Rights) standards, emphasizing detailed patent claims for pharmaceutical inventions. Argentina’s patent term generally extends 20 years from the filing date, with appropriate extensions for pharmaceuticals as per national regulations.

Scope of the Patent

The scope is primarily framed by the patent claims, which specify the technical features deemed novel and inventive. A patent’s enforceability hinges on these claims, which must neither be overly broad nor too narrow.

Claim Types

  • Product Claims: Protect specific chemical compounds, formulations, or compositions.
  • Use Claims: Cover particular therapeutic or diagnostic applications.
  • Process Claims: Relate to manufacturing or preparation methods.

In pharmaceutical patents like AR090253, the dominant claim type often revolves around novel compounds or formulations with specific therapeutic benefits.

Likely Scope of AR090253

Given standard practices, AR090253 probably claims:

  • A specific pharmaceutical formulation comprising an active ingredient combined with particular excipients.
  • A novel method of manufacturing the formulation.
  • Therapeutic use of the formulation in treating specific medical conditions.

The broadness of these claims influences the patent’s robustness: broader claims offer extensive protection but are more susceptible to invalidation for lack of novelty or inventive step. Narrow claims are safer but limit enforcement scope.

Claims Analysis

While the original claims are not provided, a typical pharmaceutical patent of this nature usually contains:

  1. Composition Claims:

    • Covering specific ratios of active ingredients and excipients.
    • Specification of stability, bioavailability, or release characteristics.
  2. Method of Use Claims:

    • Covering administration protocols or indications.
    • Highlighting innovative therapeutic applications.
  3. Process Claims:

    • Detailing manufacturing steps that improve yield or efficacy.

Assessment of Claim Strength:

  • Novelty:
    Confirmed if the claims define a unique compound or formulation not disclosed prior to the filing date. Argentina’s patent database and international patent systems serve as references for prior art.

  • Inventive Step:
    Demonstrated if the claimed invention involves a non-obvious technical improvement over existing solutions, such as enhanced bioavailability or reduced side effects.

  • Clarity & Support:
    Claims must be sufficiently clear and supported by the description, aligning with Argentina’s patent regulations.

Patent Landscape in Argentina

Argentina's pharmaceutical patent landscape is characterized by:

  • Active Local Innovation:
    Indigenous companies and multinational corporations invest in R&D, filing patents covering novel molecules, formulations, and therapeutic methods.

  • Generic Competition & Patent Challenges:
    Patent expiry or invalidation often fuels generic entry; however, patent owners actively litigate to defend their rights, especially for proprietary formulations.

  • Legal & Policy Environment:
    Local legislation allows for patent term adjustments and compliance with international standards, fostering innovation while balancing public health obligations.

Comparative Analysis:

  • Argentine patents tend to be narrowly focused, with claims tailored to specific formulations or methods.
  • The country’s patent office emphasizes detailed disclosures to prevent broad or ambiguous coverage.
  • Patent families often extend to regional filings, but local patents like AR090253 form core rights in the national landscape.

Implications for Stakeholders

  • Pharmaceutical Companies:
    Can leverage AR090253 to protect novel formulations or manufacturing processes, preventing unauthorized modifications or generics during the patent term.

  • Legal Practitioners:
    Must analyze claim language critically to evaluate infringement risks and validity challenges, guiding licensing and enforcement strategies.

  • Researchers:
    Need to navigate existing patents carefully, ensuring freedom-to-operate before developing similar formulations or therapeutic methods.

  • Regulatory Bodies:
    Must ensure patent applications meet clarity and inventive step standards, fostering a transparent ecosystem.

Conclusion

AR090253’s scope appears aligned with protecting specific pharmaceutical formulations or therapeutic methods, with claims likely tailored to demonstrate novelty and inventive step within Argentina’s patent framework. Its strategic position reinforces the importance of precise claim drafting and comprehensive prior art searches. For innovators, understanding this patent’s claims and landscape is essential for fostering R&D, strategic patent filing, and commercialization within Argentina.


Key Takeaways

  • Patent Claims Define Core Protection:
    Focus on the specificity versus breadth balance to ensure enforceability within Argentina’s patent laws.

  • Landscape Influenced by Local Innovation:
    Argentina’s patent environment favors detailed, well-supported claims tailored to regional market needs.

  • Patent Strategy Critical for Market Exclusivity:
    Patents like AR090253 serve as barriers against generic competition, emphasizing the importance of robust patent prosecution.

  • Navigating Patent Ecosystem:
    Stakeholders must stay informed on claim scope, prior art, and legal standards to optimize patent value and compliance.

  • Global & Regional Patent Considerations:
    While focusing on Argentina, align patent filings with broader regional strategies to maximize protection.


Frequently Asked Questions

1. What is the typical scope of pharmaceutical patents like AR090253 in Argentina?
They generally cover specific formulations, methods of manufacture, or therapeutic uses, with scope defined narrowly to ensure enforceability and novelty.

2. How can patent claims influence market exclusivity in Argentina?
Broader claims can extend protection, but overly broad claims risk invalidation; narrower, well-supported claims effectively deter infringement during the patent term.

3. Are regional patent landscapes similar across Latin America?
While some similarities exist, each country has distinct patent laws and examination practices, making localized landscape analysis essential.

4. What challenges exist in defending pharmaceutical patents in Argentina?
High competition from generics, challenging prior art, and potential for patent invalidation demands robust claim drafting and enforcement strategies.

5. How does patent landscape affect pharmaceutical innovation in Argentina?
A strong patent environment incentivizes R&D by providing exclusivity, but must balance public health interests through appropriate limitations and exceptions.


References

  1. National Institute of Industrial Property (INPI) Argentina. Patent Database.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. Argentinian Patent Law and Regulations (Ley de Patentes).
  4. Patent examination guidelines of INPI Argentina.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.